top of page

PCV20 in Singapore: who should consider pneumococcal vaccination?

Dr Joel Lim
Apr 25
1 min read

Updated: 1 day ago

Reviewed by Dr Joel Lim, MB CHB(UK), PG Diploma Dermatology

Full Singapore Medical Council Registration, Resident Physician, Kingsway Medical.


Originally published: 25 April 2026

Updated: 20 November 2026


Pneumococcal disease can affect the lungs and, in some cases, spread to the bloodstream or tissues surrounding the brain. Older adults and people with certain health conditions face a greater risk of serious illness. [1]


PCV20 is a pneumococcal conjugate vaccine covering 20 bacterial types. In Singapore, the national adult recommendations include pneumococcal vaccination for adults aged 65 and above, and younger adults with specified medical conditions. These include certain chronic heart, lung, kidney or liver conditions, diabetes and conditions that weaken immunity. [1,2]


Your birthday is only part of the assessment


A younger adult with a relevant medical condition may have a different vaccination need from a healthy person of the same age. Previous pneumococcal vaccination also affects the recommendation. [2]


Prepare for the appointment by bringing your medication list and vaccination history. If you are receiving specialist treatment, include the treatment name and schedule.


Keep expectations realistic


Pneumonia has several causes. Pneumococcal vaccination targets covered pneumococcal types; it does not prevent every episode of pneumonia. [3]


For people who are eligible, vaccination can reduce the risk of serious pneumococcal disease. Book a review at Kingsway Medical to check whether PCV20 is appropriate for you.


References





Related Posts

See All
bottom of page